Sales declined 2% to RON104.6 million, from RON106.7 million in the first three months of 2012, the company said in its financial report.
Ropharma posted operating income of RON105 million in the January-March period, down 2.1% on the year, while operating costs fell at a similar pace to RON101.7 million, from RON103.9 million in the year-ago period.
Ropharma is 33.24%-owned by local businessman Mihai Miron.
The company has a share capital of RON29.1 million, split into 291 million shares with a face value of RON0.1.
On the Bucharest bourse Wednesday, Ropharma closed up 6.28% at RON0.66 a share. (EUR1=RON4.3344)